Showing results (51-60 of 78) with videos related to
Sort By:
Pageof 8
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 4, 2018
Efficacy of rituximab in refractory RRMSPierre Durozard, Adil Maarouf, Clémence Boutiere, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 2, 2024
Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in FranceMathilde Lefort, Olivier Dejardin, Eric Berger, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2020
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MSMikael Cohen, Lydiane Mondot, Florence Bucciarelli, et al.Journal of the Neurological Sciences|March 23, 2016
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled studyLaure Peyro Saint Paul, Christian Creveuil, Olivier Heinzlef, et al.BMC Medical Research Methodology|May 2, 2021
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims dataNicolas H Thurin, Pauline Bosco-Levy, Patrick Blin, et al.Annals of Clinical and Translational Neurology|April 8, 2021
Comparison of Simoa<sup>TM</sup> and Ella<sup>TM</sup> to assess serum neurofilament-light chain in multiple sclerosisAudrey Gauthier, Sébastien Viel, Magali Perret, et al.Neurology|October 12, 2023
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related MortalityFabien Rollot, Zoé Uhry, Emmanuelle Dantony, et al.Neurology|July 1, 2021
Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple SclerosisIzanne Roos, Emmanuelle Leray, Romain Casey, et al.The Lancet Regional Health. Europe|November 25, 2022
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort studySarah Wilson, Floriane Calocer, Fabien Rollot, et al.Brain : a Journal of Neurology|March 1, 2011
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibilityNicolas Couturier, Florence Bucciarelli, Ramil N Nurtdinov, et al.Pageof 8